No. of Pages: 205 | Report Code: TIPRE00022771 | Category: Technology, Media and Telecommunications
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2.1 Key Insights
2.2 Market Attractiveness
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Software/Service Providers:
4.3.2 System Integrators:
4.3.3 Regulatory Bodies:
4.3.4 End-Users:
4.3.5 List of Vendors in the Value Chain
5.1 Europe Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rise in Incidences of Adverse Drug Reactions
5.2.2 Globalization of Pharmacovigilance
5.2.3 Surge in Drug Development Rates:
5.3 Market Restraints
5.3.1 High Installation and Maintenance Costs
5.4 Market Opportunities
5.4.1 Integration of Software with AI, ML, and NLP
5.5 Future Trends
5.5.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
5.6 Impact of Drivers and Restraints:
6.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
6.2 Europe Pharmacovigilance and Drug Safety Software Market Forecast and Analysis
7.1 Software
7.1.1 Overview
7.1.2 Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Services
7.2.1 Overview
7.2.2 Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
8.1 Cloud
8.1.1 Overview
8.1.2 Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2 On Premises
8.2.1 Overview
8.2.2 On Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1 Large Enterprises
9.1.1 Overview
9.1.2 Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2 SMEs
9.2.1 Overview
9.2.2 SMEs: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
10.1 Standard
10.1.1 Overview
10.1.2 Standard: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
10.2 Customized
10.2.1 Overview
10.2.2 Customized: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.1 Signal and Risk Management
11.1.1 Overview
11.1.2 Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.2 Issue Tracking and Adverse Event Tracking
11.2.1 Overview
11.2.2 Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.3 Case Management
11.3.1 Overview
11.3.2 Case Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.4 Clinical Safety Management and Clinical Trial Safety
11.4.1 Overview
11.4.2 Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.5 Quality and Compliance
11.5.1 Overview
11.5.2 Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.6 Medical Writing
11.6.1 Overview
11.6.2 Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.7 Audit Support and Training Compliance
11.7.1 Overview
11.7.2 Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.8 Healthcare Analytics
11.8.1 Overview
11.8.2 Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
11.9 Others
11.9.1 Overview
11.9.2 Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
12.1 Pharmaceutical and Biotechnology Companies
12.1.1 Overview
12.1.2 Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
12.2 Contract Research Organizations
12.2.1 Overview
12.2.2 Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
12.3 Business Process Outsourcing (BPO) Firms
12.3.1 Overview
12.3.2 Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
12.4 Others
12.4.1 Overview
12.4.2 Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1 Europe
13.1.1 Europe Pharmacovigilance and Drug Safety Software Market
13.1.2 Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecast and Analysis – by Country
13.1.2.1 Europe Pharmacovigilance and Drug Safety Software Market Revenue and Forecast and Analysis – by Country
13.1.2.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.2.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.2.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.2.3 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.2.4 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.2.5 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.2.6 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
13.1.2.3 France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.3.1 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.3.2 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.3.3 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.3.4 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.3.5 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.3.6 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
13.1.2.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.4.1 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.4.2 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.4.3 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.4.4 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.4.5 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.4.6 United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
13.1.2.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.5.1 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.5.2 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.5.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.5.4 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.5.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.5.6 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
13.1.2.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.6.1 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.6.2 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.6.3 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.6.4 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.6.5 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.6.6 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
13.1.2.7 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
13.1.2.7.1 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Offering
13.1.2.7.2 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Deployment
13.1.2.7.3 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Enterprise Size
13.1.2.7.4 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Form
13.1.2.7.5 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Functionality
13.1.2.7.6 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown by End User
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration
15.1 Overview
15.2 Market Initiative
15.3 Merger and Acquisition
16.1 ArisGlobal LLC
16.1.1 Key Facts
16.1.2 Business Description
16.1.3 Products and Services
16.1.4 Financial Overview
16.1.5 SWOT Analysis
16.1.6 Key Developments
16.2 Max Application
16.2.1 Key Facts
16.2.2 Business Description
16.2.3 Products and Services
16.2.4 Financial Overview
16.2.5 SWOT Analysis
16.2.6 Key Developments
16.3 Oracle Corp
16.3.1 Key Facts
16.3.2 Business Description
16.3.3 Products and Services
16.3.4 Financial Overview
16.3.5 SWOT Analysis
16.3.6 Key Developments
16.4 Veeva Systems Inc
16.4.1 Key Facts
16.4.2 Business Description
16.4.3 Products and Services
16.4.4 Financial Overview
16.4.5 SWOT Analysis
16.4.6 Key Developments
16.5 IQVIA Holdings Inc
16.5.1 Key Facts
16.5.2 Business Description
16.5.3 Products and Services
16.5.4 Financial Overview
16.5.5 SWOT Analysis
16.5.6 Key Developments
16.6 ICON Plc
16.6.1 Key Facts
16.6.2 Business Description
16.6.3 Products and Services
16.6.4 Financial Overview
16.6.5 SWOT Analysis
16.6.6 Key Developments
16.7 Cognizant Technology Solutions Corp
16.7.1 Key Facts
16.7.2 Business Description
16.7.3 Products and Services
16.7.4 Financial Overview
16.7.5 SWOT Analysis
16.7.6 Key Developments
16.8 Accenture Plc
16.8.1 Key Facts
16.8.2 Business Description
16.8.3 Products and Services
16.8.4 Financial Overview
16.8.5 SWOT Analysis
16.8.6 Key Developments
16.9 Syneos Health Inc
16.9.1 Key Facts
16.9.2 Business Description
16.9.3 Products and Services
16.9.4 Financial Overview
16.9.5 SWOT Analysis
16.9.6 Key Developments
16.10 Genpact Ltd.
16.10.1 Key Facts
16.10.2 Business Description
16.10.3 Products and Services
16.10.4 Financial Overview
16.10.5 SWOT Analysis
16.10.6 Key Developments
16.11 AB Cube S.A.S.
16.11.1 Key Facts
16.11.2 Business Description
16.11.3 Products and Services
16.11.4 Financial Overview
16.11.5 SWOT Analysis
16.11.6 Key Developments
16.12 Laboratory Corp of America Holdings
16.12.1 Key Facts
16.12.2 Business Description
16.12.3 Products and Services
16.12.4 Financial Overview
16.12.5 SWOT Analysis
16.12.6 Key Developments
16.13 Parexel International Corp
16.13.1 Key Facts
16.13.2 Business Description
16.13.3 Products and Services
16.13.4 Financial Overview
16.13.5 SWOT Analysis
16.13.6 Key Developments
16.14 Qinecsa Solutions
16.14.1 Key Facts
16.14.2 Business Description
16.14.3 Products and Services
16.14.4 Financial Overview
16.14.5 SWOT Analysis
16.14.6 Key Developments
16.15 Clinevo Technologies
16.15.1 Key Facts
16.15.2 Business Description
16.15.3 Products and Services
16.15.4 Financial Overview
16.15.5 SWOT Analysis
16.15.6 Key Developments
17.1 Word Index
17.2 About the Insight Partners
Table 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation
Table 2. List of Vendors
Table 3. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Table 4. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 5. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 6. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 7. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 8. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 9. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 10. Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Country
Table 11. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 12. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 13. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 14. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 15. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 16. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 17. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 18. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 19. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 20. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 21. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 22. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 23. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 24. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 25. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 26. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 27. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 28. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 29. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 30. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 31. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 32. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 33. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 34. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 35. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 36. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 38. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 39. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 40. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 41. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Offering
Table 42. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Deployment
Table 43. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Enterprise Size
Table 44. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Form
Table 45. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by Functionality
Table 46. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand) – by End User
Table 47. Company Positioning & Concentration
Table 48. List of Abbreviation
Figure 1. Europe Pharmacovigilance and Drug Safety Software Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021–2031
Figure 5. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Offering, 2023 and 2031
Figure 6. Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 7. Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Deployment, 2023 and 2031
Figure 9. Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. On Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 11. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Enterprise Size, 2023 and 2031
Figure 12. Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. SMEs: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Form, 2023 and 2031
Figure 15. Standard: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 16. Customized: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 17. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by Functionality, 2023 and 2031
Figure 18. Signal and Risk Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 19. Issue Tracking and Adverse Event Tracking: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 20. Case Management: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 21. Clinical Safety Management and Clinical Trial Safety: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 22. Quality and Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 23. Medical Writing: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 24. Audit Support and Training Compliance: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 25. Healthcare Analytics: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 26. Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 27. Europe Pharmacovigilance and Drug Safety Software Market Share (%) – by End User, 2023 and 2031
Figure 28. Pharmaceutical and Biotechnology Companies: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 29. Contract Research Organizations: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 30. Business Process Outsourcing (BPO) Firms: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 31. Others: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 32. Europe Pharmacovigilance and Drug Safety Software Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 33. Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 34. France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 35. United Kingdom: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 36. Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 37. Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 38. Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 39. Heat Map Analysis by Key Players
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Pharmacovigilance and Drug Safety Software Market
